Cargando…
Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648570/ https://www.ncbi.nlm.nih.gov/pubmed/34969528 http://dx.doi.org/10.1016/j.thromres.2021.12.003 |
| _version_ | 1784610835085131776 |
|---|---|
| author | Rashidi, Farid Barco, Stefano Rezaeifar, Parisa Sadeghipour, Parham Ghodrati, Samad Bakhshandeh, Hooman Mousavi-Aghdas, Seyed Ali Sadeghi, Armin Sharifi, Akbar Valizadeh, Hamed Mikaeili, Haleh Rafiee, Farnaz Navarbaf, Zahar Farajian, Gita Mahmoodpoor, Ata Bikdeli, Behnood Ansarin, Khalil |
| author_facet | Rashidi, Farid Barco, Stefano Rezaeifar, Parisa Sadeghipour, Parham Ghodrati, Samad Bakhshandeh, Hooman Mousavi-Aghdas, Seyed Ali Sadeghi, Armin Sharifi, Akbar Valizadeh, Hamed Mikaeili, Haleh Rafiee, Farnaz Navarbaf, Zahar Farajian, Gita Mahmoodpoor, Ata Bikdeli, Behnood Ansarin, Khalil |
| author_sort | Rashidi, Farid |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8648570 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86485702021-12-07 Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial Rashidi, Farid Barco, Stefano Rezaeifar, Parisa Sadeghipour, Parham Ghodrati, Samad Bakhshandeh, Hooman Mousavi-Aghdas, Seyed Ali Sadeghi, Armin Sharifi, Akbar Valizadeh, Hamed Mikaeili, Haleh Rafiee, Farnaz Navarbaf, Zahar Farajian, Gita Mahmoodpoor, Ata Bikdeli, Behnood Ansarin, Khalil Thromb Res Article Elsevier Ltd. 2022-08 2021-12-07 /pmc/articles/PMC8648570/ /pubmed/34969528 http://dx.doi.org/10.1016/j.thromres.2021.12.003 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Rashidi, Farid Barco, Stefano Rezaeifar, Parisa Sadeghipour, Parham Ghodrati, Samad Bakhshandeh, Hooman Mousavi-Aghdas, Seyed Ali Sadeghi, Armin Sharifi, Akbar Valizadeh, Hamed Mikaeili, Haleh Rafiee, Farnaz Navarbaf, Zahar Farajian, Gita Mahmoodpoor, Ata Bikdeli, Behnood Ansarin, Khalil Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial |
| title | Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial |
| title_full | Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial |
| title_fullStr | Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial |
| title_full_unstemmed | Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial |
| title_short | Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial |
| title_sort | tissue plasminogen activator for the treatment of adults with critical covid-19: a pilot randomized clinical trial |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648570/ https://www.ncbi.nlm.nih.gov/pubmed/34969528 http://dx.doi.org/10.1016/j.thromres.2021.12.003 |
| work_keys_str_mv | AT rashidifarid tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT barcostefano tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT rezaeifarparisa tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT sadeghipourparham tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT ghodratisamad tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT bakhshandehhooman tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT mousaviaghdasseyedali tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT sadeghiarmin tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT sharifiakbar tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT valizadehhamed tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT mikaeilihaleh tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT rafieefarnaz tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT navarbafzahar tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT farajiangita tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT mahmoodpoorata tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT bikdelibehnood tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial AT ansarinkhalil tissueplasminogenactivatorforthetreatmentofadultswithcriticalcovid19apilotrandomizedclinicaltrial |